Gabrail Cancer Center   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Canton OH United States (1990)

Organization Overview

First Clinical Trial
2007
NCT00442598
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CEO, President, Gabrail Cancer Center | Gabrail Cancer Center Research